MedPath

A study of blood letting and panchkarma procedure (oleation and sudation termed as Janu Basti) in the management of osteoarthritis knee pain.

Phase 2
Conditions
Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Registration Number
CTRI/2022/09/045698
Lead Sponsor
Shri Krishna Govt Ayurvedic College Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients aged 40-70 years.

Clinical signs, symptoms, and history of present illness suggestive of primary

osteoarthritis (grade 2and grade 3)

Exclusion Criteria

ââ? â?? Patients having age less than 40 year and more than 70 years.

ââ? â?? Patients having inconclusive diagnosis.

ââ? â?? Traumatic arthritis, rheumatoid arthritis, psoriatic arthritis, gouty arthritis and

other secondary osteoarthritis.

ââ? â?? Grade 1, Grade 4, Grade 518 type of primary osteoarthritis will be excluded.

ââ? â?? Patients having cardiac disease, renal disease, endocrine disorders and

malignancy will be excluded in the study to avoid overlapping of

symptomatology.

ââ? â?? Coagulopathy disorders will be excluded.

ââ? â?? Severe Anemia, pregnancy, any kind of noted drug allergy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare Raktavasechan (Jalaukavacharana) and Janu Basti in the management of Janu Sandhigata Vata (Osteoarthritis-knee jointsTimepoint: 1. Jalauka used for Blood Letting 4 times in 21 days <br/ ><br>0th day - 1st visit for blood letting <br/ ><br>7th day - 2nd visit for blood letting <br/ ><br>14th day - 3rd visit for blood letting 21th day - 4th visit for blood letting <br/ ><br> <br/ ><br>2. Janu Basti will be done once in a day for 21 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Changes in osteoarthritic features (pain, stiffness, inflammation and restricted movement) and improvement in life style along with other <br/ ><br>subjective parameters.Timepoint: Each patient has 21 days study period. <br/ ><br>Patient will be assessed weekly to check the improvement in subjective parameters.
© Copyright 2025. All Rights Reserved by MedPath